Skip to main content
SpringerLink
Log in

Insulin lispro Mix25: a guide to its use in diabetes mellitus

  • Drug and Profile Reports
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

Notes

  1. The use of trade names is for product identification purposes only and does not imply endorsement.

References

  1. Simpson D, McCormack PL, Keating GM, et al. Insulin lispro: a review of its use in the management of diabetes mellitus. Drugs 2007; 67(3): 407–34

    Article  PubMed  CAS  Google Scholar 

  2. European Medicines Agency. Humalog® Mix25 (25% insulin lispro solution and 75% insulin lispro protamine suspension) injection: summary of product characteristics [online]. Available from: http://www.emea.europa.eu [Accessed 2008 Apr 2]

  3. Oiknine R, Bernbaum M, Mooradian AD. A critical appraisal of the role of insulin analogues in the management of diabetes mellitus. Drugs 2005; 65(3): 325–40

    Article  PubMed  CAS  Google Scholar 

  4. Heise T, Weyer C, Serwas A, et al. Time-action profile of novel premixed preparations of insulin lispro and NPL insulin. Diabetes Care 1998 May; 21: 800–3

    Article  PubMed  CAS  Google Scholar 

  5. Roach P, Trautmann M, Arora V, et al. Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations, insulin lispro Mix25 and insulin lispro Mix50. Clin Ther 1999 Mar; 21: 523–34

    Article  PubMed  CAS  Google Scholar 

  6. Galic E, Vrtovec M, Bozikov V, et al. The impact of the timing of Humalog Mix25 injections on blood glucose fluctuations in the postprandial period in elderly patients with type 2 diabetes. Med Sci Monit 2005 Dec; 11(12): PI87–92

    PubMed  CAS  Google Scholar 

  7. Herz M, Sun B, Milicevic Z, et al. Comparative efficacy of preprandial or postprandial Humalog Mix75/25 versus glyburide in patients 60 to 80 years of age with type 2 diabetes mellitus. Clin Ther 2002 Jan; 24: 73–86

    Article  PubMed  CAS  Google Scholar 

  8. Roach P, Koledova E, Metcalfe S, et al. Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide. Clin Ther 2001 Oct; 23: 1732–44

    Article  PubMed  CAS  Google Scholar 

  9. Malone JK, Bai S, Campaigne BN, et al. Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with Type 2 diabetes. Diabet Med 2005 Apr; 22(4): 374–81

    Article  PubMed  CAS  Google Scholar 

  10. Niskanen L, Jensen LE, Rastam J, et al. Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus. Clin Ther 2004 Apr; 26(4): 531–40

    Article  PubMed  CAS  Google Scholar 

  11. Roach P, Yue L, Arora V, et al. Improved postprandial glycemic control during treatment with Humalog Mix25, or a novel protamine-based insulin lispro formulation. Diabetes Care 1999 Aug; 22: 1258–61

    Article  PubMed  CAS  Google Scholar 

  12. European Diabetes Policy Group 1999. A desktop guide to type 2 diabetes mellitus. Diabet Med 1999; 16(9): 716–30

    Article  Google Scholar 

  13. European Diabetes Policy Group 1998. A desktop guide to type 1 (insulin-dependent) diabetes mellitus. Diabet Med 1999; 16(3): 253–66

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Insulin lispro Mix25: a guide to its use in diabetes mellitus. Drugs Ther. Perspect 24, 1–4 (2008). https://doi.org/10.2165/00042310-200824080-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200824080-00001

Search

Navigation